Bio-Techne (TECH) Competitors

Agilent Technologies (NYSE:A) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, community ranking, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Do analysts rate A or TECH?

Agilent Technologies currently has a consensus price target of $146.15, indicating a potential upside of 21.07%. Bio-Techne has a consensus price target of $81.25, indicating a potential upside of 34.05%. Given Bio-Techne's stronger consensus rating and higher probable upside, analysts plainly believe Bio-Techne is more favorable than Agilent Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Bio-Techne	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56

Which has higher valuation & earnings, A or TECH?

Agilent Technologies has higher revenue and earnings than Bio-Techne. Agilent Technologies is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.51B	5.29	$1.29B	$4.35	27.75
Bio-Techne	$1.20B	8.01	$168.10M	$0.99	61.22

Is A or TECH more profitable?

Agilent Technologies has a net margin of 19.27% compared to Bio-Techne's net margin of 13.22%. Agilent Technologies' return on equity of 25.56% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.27%	25.56%	13.47%
Bio-Techne	13.22%	12.73%	9.75%

Which has more volatility & risk, A or TECH?

Agilent Technologies has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500.

Does the MarketBeat Community prefer A or TECH?

Agilent Technologies received 467 more outperform votes than Bio-Techne when rated by MarketBeat users. Likewise, 71.08% of users gave Agilent Technologies an outperform vote while only 62.38% of users gave Bio-Techne an outperform vote.

Company	Underperform	Outperform
Agilent Technologies	Outperform Votes 865 71.08%	Underperform Votes 352 28.92%
Bio-Techne	Outperform Votes 398 62.38%	Underperform Votes 240 37.62%

Is A or TECH a better dividend stock?

Agilent Technologies pays an annual dividend of $0.99 per share and has a dividend yield of 0.8%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.5%. Agilent Technologies pays out 22.8% of its earnings in the form of a dividend. Bio-Techne pays out 32.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio.

Do institutionals & insiders believe in A or TECH?

98.9% of Bio-Techne shares are owned by institutional investors. 3.9% of Bio-Techne shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Does the media refer more to A or TECH?

In the previous week, Agilent Technologies had 17 more articles in the media than Bio-Techne. MarketBeat recorded 38 mentions for Agilent Technologies and 21 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.08 beat Agilent Technologies' score of 1.07 indicating that Bio-Techne is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	23 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Bio-Techne	13 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Agilent Technologies beats Bio-Techne on 12 of the 20 factors compared between the two stocks.